Commercialization: Page 86

PharmaVoice Team/PharmaVoice

The Technologists

Valdo Arnera, M.D. Bill Byrom, Ph.D. Philip A. Garland Keith Howells Don Schenker Rodney Spady A creative and passionate approach to pioneering new areas of technology applications and new products has enabled Dr. Bill Byrom to engender real improvements in the drug development process. For the p...
By PharmaVoice Team • July 24, 2008
PharmaVoice Team/PharmaVoice

The Brand Champions

Jose De Leon Camille DeSantis Susan Dorfman Bill Drummy John Harrington Michael Laferrera Kathy Magnuson Bob Mason Renee Mellas Stephen Neale Linda Richardson Mike Rutstein The Brand Champions MILLIONS OF DOLLARS AND MANY YEARS — IN SOME CASES, DECADES — ARE SPENT MOVING A PRODUCT FROM THE CLINIC...
By PharmaVoice Team • July 24, 2008
PharmaVoice Team/PharmaVoice

The Entrepreneurs

Simon Chin Gerianne Tringali DiPiano Dan Donovan Stephen Gerard Jane Hollingsworth Ramin Najafi, Ph.D. Chris Porter Sandeep Shah Howard Steinberg Christoph Westphal, M.D., Ph.D. Carl Whatley Stan Woodland STARTING A BUSINESS IS EASY.MAKING IT SUCCESSFUL IS ANOTHER STORY. These innovative, forward...
By PharmaVoice Team • July 24, 2008
PharmaVoice Team/PharmaVoice

The Commanders & Chiefs

LEADERS ARE MADE,THEY ARE NOT BORN.THEY ARE MADE BY HARD EFFORT,WHICH IS THE PRICE ALL OF US MUST PAY TO ACHIEVE ANY GOAL THAT IS WORTHWHILE. This quote from the great NFL coach Vince Lombardi sums up the collective excellence of this groupof company leaders,who are taking their organizations to ...
By PharmaVoice Team • July 24, 2008
PharmaVoice Team/PharmaVoice

Who's on the List

The PHARMAVOICE Indexed by Company Affiliation Abbott Colleen Foley AbelsonTaylor Stephen Neale Actelion Pharmaceuticals Ltd. Martine Clozel, M.D. AstraZeneca Geert J.C.M. Kolvenbag M.D., Ph.D., F.F.P.M Barrier Therapeutics Inc. Michael Laferrera BearingPoint Inc. Philip A. Garland Blue Fin Group...
By PharmaVoice Team • July 24, 2008
PharmaVoice Team/PharmaVoice

Who's on the List - 2008 - By section

July / August 2008 PharmaVOICE The PHARMAVOICE 100 Jeffrey S. Aronin Ovation Pharmaceuticals Inc. Gerianne T. DiPiano FemmePharma Global Healthcare Inc. Chris Porter Clinipace Inc. Kathleen Drennan Iris Global Clinical Trial Solutions Jason Appel SanofiAventis Adriann Sax King Pharmaceuticals Inc...
By PharmaVoice Team • July 24, 2008
PharmaVoice Team/PharmaVoice

Clinical Operations: Bringing All of the Pieces Together

6 June 20 08 VIEW on Clinical Operations THE FORUM A recentTufts CSDD study cites research showing that the cost to develop a new biopharmaceutical is now more than $1 billion. Accordingly, clinical organizations are under growing pressure to reduce research and development costs while accelerati...
By PharmaVoice Team • June 9, 2008
PharmaVoice Team/PharmaVoice

Evaluating and Allocating Advertising Budgets: A Sponsor's Responsibility

36 June 20 08 VIEW on Clinical Operations PATIENT RECRUITMENT E valuating and allocating costefficient, yet costeffective advertising bud gets for a patient recruiting campaign is an issue that rarely receives the attention it deserves. A wellplanned budget is absolutely integral to the success o...
By PharmaVoice Team • June 9, 2008
PharmaVoice Team/PharmaVoice

Avoiding the Five Common Errors Made in Implementing a CTMS

22 June 20 08 VIEW on Clinical Operations ECLINICAL I n recent years, the management of clinical trials has become increasing ly complex as the size, geographic diversity, and complexity of trials grows. Managing these highly complex trials requires the study manag er to be in control of a wide r...
By PharmaVoice Team • June 9, 2008
PharmaVoice Team/PharmaVoice

Supplier Showcase

Showcase 42 June 20 08 VIEW on Clinical Operations Ateb Inc. 4501 Atlantic Ave. Ste. 110 Raleigh, NC 27604 Phone: 9198824935 www.ateb.com Pharmacy Outreach via Patient Messaging Solutions Ateb provides Pharmacy Outreach through our Patient Messaging Solutions; a unique inbound and outbound bridge...
By PharmaVoice Team • June 9, 2008
PharmaVoice Team/PharmaVoice

Mass Customization of Physician Messaging

While the pharmaceutical industry cannot adopt mass customization in the manufacture of its products, it can adopt mass customization in the marketing of its products to physicians, enabling sales reps to impart added value in presenting product information to the customer: physicians. Research s...
By PharmaVoice Team • May 28, 2008
PharmaVoice Team/PharmaVoice

DIA Preview Showcase

SPECIAL FEATURE DIA 44TH ANNUAL MEETING Representing more than 20,000 members worldwide involved in discovery, development, regulation, and marketing of bio/phar maceutical and related products, the Drug Information Association (DIA) each year has the significant task of designing an annual meeti...
By PharmaVoice Team • May 28, 2008
PharmaVoice Team/PharmaVoice

Redefining the Salesforce Landscape

BY ROBIN ROBINSON One of the driving factors to find new new solutions is the looming loss of patent protection for several blockbuster drugs. “We are two years away from Lipitor going off patent, which means we are one year closer to Armageddon, and things are going to get really ugly,” says Mat...
By Robin Robinson • May 27, 2008
PharmaVoice Team/PharmaVoice

Reaching Patients in the Pharmacy

BY ROBIN ROBINSON It’s not an emerging trend, because it has been in practice for years. It’s not exactly a growing trend, because although there has been more uptake, it is still “underutilized” as a marketing medium. However, pharma companies that use DTC programs at the pharmacy level have fou...
By Robin Robinson • May 27, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

Pharma POOL Dr. Nancy JOSEPHRIDGE Alan MACKENZIE Takeda Unveils PostTAP Executive Structure Takeda Pharmaceuticals North America (TPNA), Deerfield, Ill., has announced leader ship changes as part of the closing of TAP Pharmaceutical Products, the U.S.based joint venture between Abbott Laboratorie...
By PharmaVoice Team • May 27, 2008
PharmaVoice Team/PharmaVoice

E-Media

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ForteBio has launched the Octet RED System, an affordable, user friendly tool for labelfree, realtime kinetic analysis of small molecules, peptides, and proteins for research, development, and bio processing. The system is based on...
By PharmaVoice Team • May 27, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

As patients live longer and are increasingly diagnosed with chronic and often debilitating ailments, pharmaceutical decisionmakers find themselves examining ways to adapt their organizations to address the resulting healthcare needs in both human and business terms. According to the report, the p...
By PharmaVoice Team • May 27, 2008
PharmaVoice Team/PharmaVoice

PharmaOutlet

Here is an issue that has eluded the industry since its inception: how do physicians and patients really speak with one another in office visits? It is a question many people have asked, but few have answered. There is an absolute need to understand how physicians and patients actually interact w...
By Meaghan Onofrey • May 27, 2008
PharmaVoice Team/PharmaVoice

UpFront

THE OTC MARKET Plop,Plop, Fizz, Fizz Consumers are taking an increasingly active role in self medication because of rising healthcare costs, a large uninsured population, and ever more choices in OTC products. Purchasing OTC drugs also is more convenient and money is saved avoiding doctor’s visit...
By PharmaVoice Team • May 27, 2008
PharmaVoice Team/PharmaVoice

Raise your voice: Letters

Digital Training With the emergence of digital technology as the fastest growing means of delivering brand marketing and messaging, digital training is one of the best investments agencies can make to address the increasing pressures and speed of change cited by so many of your experts in the Apr...
By PharmaVoice Team • May 27, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

It’s that time of year again, what we jokingly refer to as “conference season.” As everyone heads into several months of exhibitions, informative sessions, and symposia with lanyards in tow, we thought it would be a good idea to provide some best practices for getting the most out of your confere...
By Taren Grom • May 27, 2008
PharmaVoice Team/PharmaVoice

A View on Sales — A Year ofTransformation

6 May 20 08 VIEW on Sales THE FORUM FROM GENERALISTS TO SPECIALISTS Pharma salesforces already have made some moves toward greater therapeutic specialization, in part because physicians have expressed a marked preference for specialty sales reps. According to data from Verispan, most physicians p...
By PharmaVoice Team • May 7, 2008
PharmaVoice Team/PharmaVoice

Today's Preceptorship: Staying Afloat Without the Sale

24 May 20 08 VIEW on Sales TRAINING MODELS et’s face it, the word “preceptorship” has gotten a bad rap. And it’s no wonder, considering the boatload of codes, guidelines, standards — and lawsuits — that have reached our industry shores in recent years. Paying clinicians to educate has become a gu...
By PharmaVoice Team • May 7, 2008
PharmaVoice Team/PharmaVoice

Making It Stick: How to Maximize Knowledge Retention

22 May 20 08 VIEW on Sales TRAINING MODELS T oo often, training leaders simply develop and conduct training that supports an organizational initiative — launch of a new product, release of a new messaging campaign, strategy to blunt a new competitor, rollout of a new sales force automation solu t...
By PharmaVoice Team • May 7, 2008
PharmaVoice Team/PharmaVoice

Driving Sales Excellence Through Competency Modeling

20 May 20 08 VIEW on Sales TALENT DEVELOPMENT I n the increasingly competitive marketplace of the pharmaceutical industry, a high performance salesforce is perhaps the most critical source of competitive advantage.Attracting and selecting the right tal ent is essential to success, given both curr...
By PharmaVoice Team • May 7, 2008